135 related articles for article (PubMed ID: 34751436)
1. Comparing the CT and MRI findings for canine primary hepatocellular lesions.
Kurokawa S; Tanaka T; Yamazaki H; Noguchi S; Wada Y; Nishida H; Akiyoshi H
Vet Rec; 2022 Jun; 190(11):e1083. PubMed ID: 34751436
[TBL] [Abstract][Full Text] [Related]
2. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.
Ohama H; Imai Y; Nakashima O; Kogita S; Takamura M; Hori M; Seki Y; Sawai Y; Igura T; Fukuda K; Makino Y; Morimoto O; Ohsawa M; Sakamoto M; Murakami T
J Gastroenterol; 2014 Jun; 49(6):1081-93. PubMed ID: 23903870
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.
Chen C; Zhao H; Fu X; Huang L; Tang M; Yan X; Sun S; Jia W; Mao L; Shi J; Chen J; He J; Zhu J; Qiu Y
Oncotarget; 2017 May; 8(18):29741-29750. PubMed ID: 28392502
[TBL] [Abstract][Full Text] [Related]
4. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.
Saito K; Kotake F; Ito N; Ozuki T; Mikami R; Abe K; Shimazaki Y
Magn Reson Med Sci; 2005; 4(1):1-9. PubMed ID: 16127248
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm.
Mita K; Kim SR; Kudo M; Imoto S; Nakajima T; Ando K; Fukuda K; Matsuoka T; Maekawa Y; Hayashi Y
World J Gastroenterol; 2010 Sep; 16(33):4187-92. PubMed ID: 20806437
[TBL] [Abstract][Full Text] [Related]
6. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
[TBL] [Abstract][Full Text] [Related]
7. [The predictive value of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced MRI imaging features combined with quantitative parameters for the pathologic grading of hepatocellular carcinoma].
Hu MJ; Yu YX; Fan YF; Jiang YM; Hu S; Wang XM; Hu CH
Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1299-1304. PubMed ID: 32375436
[No Abstract] [Full Text] [Related]
8. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
[TBL] [Abstract][Full Text] [Related]
9. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.
Kim YN; Song JS; Moon WS; Hwang HP; Kim YK
Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.
Inoue T; Kudo M; Komuta M; Hayaishi S; Ueda T; Takita M; Kitai S; Hatanaka K; Yada N; Hagiwara S; Chung H; Sakurai T; Ueshima K; Sakamoto M; Maenishi O; Hyodo T; Okada M; Kumano S; Murakami T
J Gastroenterol; 2012 Sep; 47(9):1036-47. PubMed ID: 22526270
[TBL] [Abstract][Full Text] [Related]
11. Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria.
Rhee H; Kim MJ; Park YN; Choi JS; Kim KS
J Magn Reson Imaging; 2012 Feb; 35(2):393-8. PubMed ID: 21990116
[TBL] [Abstract][Full Text] [Related]
12. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow.
Kogita S; Imai Y; Okada M; Kim T; Onishi H; Takamura M; Fukuda K; Igura T; Sawai Y; Morimoto O; Hori M; Nagano H; Wakasa K; Hayashi N; Murakami T
Eur Radiol; 2010 Oct; 20(10):2405-13. PubMed ID: 20490505
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies.
Li J; Wang J; Lei L; Yuan G; He S
Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172
[TBL] [Abstract][Full Text] [Related]
15. A study on the inconsistency of arterial phase hypervascularity detection between contrast-enhanced ultrasound using sonazoid and gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid magnetic resonance imaging of hepatocellular carcinoma lesions.
Wang F; Numata K; Chuma M; Miwa H; Moriya S; Ogushi K; Okada M; Otani M; Inayama Y; Maeda S
J Med Ultrason (2001); 2021 Apr; 48(2):215-224. PubMed ID: 33721130
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy for macroscopic classification of nodular hepatocellular carcinoma: comparison of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and angiography-assisted computed tomography.
Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Okuda S; Ogawa S; Igura T; Imai Y
J Gastroenterol; 2015 Jan; 50(1):85-94. PubMed ID: 24563123
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
[TBL] [Abstract][Full Text] [Related]
18. HCC-to-liver contrast on arterial-dominant phase images of EOB-enhanced MRI: comparison with dynamic CT.
Kanata N; Yoshikawa T; Ohno Y; Kanda T; Uchida K; Izaki K; Fukumoto T; Ku Y; Itoh T; Kitajima K; Takahashi S; Sugimura K
Magn Reson Imaging; 2013 Jan; 31(1):17-22. PubMed ID: 22898685
[TBL] [Abstract][Full Text] [Related]
19. SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings.
Kim SH; Lee WJ; Lim HK; Park CK
Korean J Radiol; 2009; 10(2):112-20. PubMed ID: 19270856
[TBL] [Abstract][Full Text] [Related]
20. Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging is more effective than enhanced 64-slice CT for the detection of small lesions in patients with hepatocellular carcinoma.
Li J; Li X; Weng J; Lei L; Gong J; Wang J; Li Z; Zhang L; He S
Medicine (Baltimore); 2018 Dec; 97(52):e13964. PubMed ID: 30593219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
